1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. ASARFI HOSPITAL LTD.
Asarfi Hospital Ltd.
BSE: 543943

Asarfi Hospital Live Share Price Today, Share Analysis and Chart

aboutAsarfi Hospital Ltd. is a healthcare provider primarily operating in Dhanbad, Jharkhand. The company operates as a multispecialty healthcare facility providing a range of medical services including tertiary care. It serves the regional population wit... Read More
Ask AI about Asarfi Hospital
173.20-6.75(-3.75%)
34,000
BSE Volume

BSE 19 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Asarfi Hospital Stock Price Ranges

Day Price Range

-3.8% 1 Day return
173.2 (LTP)
173180
LowHigh

Week Price Range

-5.4% 1 Week return
173.2 (LTP)
173198.4
LowHigh

Month Price Range

-9.5% 1 Month return
173.2 (LTP)
155198.4
LowHigh

52 Week Price Range

-15.2% 1 Year return
173.2 (LTP)
147.7257
LowHigh

Asarfi Hospital Technical Analysis

Asarfi Hospital EMA & SMA

Bearish-8
Bullish0
Bearish8
5 Day179.5
10 Day180.0
12 Day179.9
20 Day179.8
26 Day180.4
50 Day184.9
100 Day191.5
200 Day189.3

Asarfi Hospital Delivery And Volume

Daily Avg. Delivery Volume %
19 Nov, 202652.9%
Week73.9%
Month75.3%
PositiveNeutralNegative

Asarfi Hospital Resistance and Support

175.40
Pivot
First Resistance177.8
Second Resistance182.4
Third Resistance184.8
First Support170.8
Second Support168.4
Third Support163.8
Day RSI44.5
Day MACD-0.5
Day MFI72.5
Day MACD Signal Line-1.2

Asarfi Hospital Beta

1 Month1.9
1 Year0.9
3 Month0.8
3 Year0.2

Asarfi Hospital Price Change Analysis

↓-9.5%
Over 1 Month
LowHigh
155.0198.5
↓-29.0%
Over 3 Months
LowHigh
155.0248.4
↓-11.4%
Over 6 Months
LowHigh
155.0248.4
↓-15.2%
Over 1 Year
LowHigh
147.7257.0

Asarfi Hospital Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Harendra SinghPromoter3,695,90018.8 %
Gopal SinghPublic472,6202.4 %
India-Ahead Venture FundDii296,0001.5 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Asarfi Hospital Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
HARISHKUMARGUPTABulkSell23 May 2025106.99100,000BSE
HARISHKUMARGUPTABulkPurchase09 May 2025106.94100,000BSE
ULTRA SIGMA PRIVATE LIMITEDBulkPurchase18 Mar 202579.38100,000BSE
NEW BERRY ADVISORS LTDBulkSell18 Mar 202579.38100,000BSE
ANG CORPORATE SERVICES PVT LTDBulkPurchase15 Mar 202460.96200,000BSE
VALUE PROLIFIC CONSULTING SERVICES PVT LTDBulkSell15 Mar 202460.96200,000BSE
NAMRATA CHANDRAPRAKASH KHANDELWALBulkSell07 Mar 202472.09119,000BSE
JINENDRA KUMAR JAINBulkPurchase07 Mar 202472.10116,000BSE
VINEY EQUITY MARKET LLPBulkSell19 Jan 202496.03155,000BSE
NAMRATA CHANDRAPRAKASH KHANDELWALBulkPurchase19 Jan 202496.04140,000BSE

Asarfi Hospital Corporate Actions

Asarfi Hospital Board Meetings

Asarfi Hospital past and upcoming board meetings.

#Ex-Date
PurposeNotes
113 Nov 2026
Half Yearly Results-
225 Aug 2026
A.G.M.-
307 Aug 2026
Quarterly Results-
411 May 2026
Audited Results-
509 Feb 2026
Quarterly Results-

Asarfi Hospital Corporate Filings

Asarfi Hospital BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
19 Nov 2026
Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that Asarfi Hospital Limited has scheduled a Conference Call with Analysts / Investors on Tuesday, November 24, 2026, at 04:00 P.M. (IST) to discuss the Audited Financial Results of the Company for the quarter and half year ended September 30, 2026.
PDF
14 Nov 2026
Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Outcome of Press Release/Media Release Under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015.
PDF
13 Nov 2026
Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Submission of Press Release of the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30 September 2026.
PDF
13 Nov 2026
Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Submission of Investor Presentation of Asarfi Hospital Limited for the Quarter & Half Year ended September 30,2026.
PDF
13 Nov 2026
Asarfi Hospital Ltd - 543943 - Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026
We wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i:e, 13th November 2026, has considered and approved the unaudited Standalone and Consolidated Financial Results of the company for the quarter ended 30th September 2026.
PDF

Asarfi Hospital Documents

Asarfi Hospital Earnings Call

Asarfi Hospital earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
30 May 2026Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
22 Nov 2025Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14 May 2025Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
09 Nov 2024Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06 Nov 2024Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Asarfi Hospital Annual Reports

Asarfi Hospital financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024
2023Annual Report Mar-2023

Asarfi Hospital Credit Ratings

Asarfi Hospital credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
06 Oct 2026crisil ratingsAsarfi Hospital LimitedAsarfi Hospital Limited:Long-term rating upgraded to 'Crisil BBB / Stable'; 'Crisil A3+' assigned to short-term bank debt; Rated amount enhanced for Bank Debt
09 Oct 2025crisil ratingsAsarfi Hospital LimitedAsarfi Hospital Limited:'Crisil BBB-/Stable' assigned to Bank Debt
25 Sep 2025care ratingsAsarfi Hospital Limited
05 Sep 2024care ratingsAsarfi Hospital Limited
15 May 2024care ratingsAsarfi Hospital Limited

Asarfi Hospital Investor Presentations

Asarfi Hospital investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
13 Nov 2026Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation
07 Aug 2026Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation
11 May 2026Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation
09 Feb 2026Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation
10 Nov 2025Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation

Asarfi Hospital - Company Profile

Asarfi Hospital Management Structure

Asarfi Hospital management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Harendra SinghChief Financial Officer42Mar 26
SUDIPA SINGHCompany Secretary,Compliance Officer1.92Mar 26

Asarfi Hospital Board of Directors

Asarfi Hospital Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Udai Pratap SinghED / MD / Promoter24Mar 25
GOPAL SINGHExecutive Director8.4Mar 25
Madhuri SinghExecutive Director6Mar 25
AMIT KUMAR BARNWALIndependent Non Exe. Director0.94Mar 25
Rajkumari SharmaIndependent Non Exe. Director0.8Mar 25
Sukanti Kumar DasNon Executive Director-Mar 25
SUDIPA SINGHCompany Sec. & Compli. Officer-Mar 25

About the company - Business Profile

Asarfi Hospital Ltd. is a healthcare provider primarily operating in Dhanbad, Jharkhand. The company operates as a multispecialty healthcare facility providing a range of medical services including tertiary care. It serves the regional population with specialized departments such as Cardiology, Neurosciences, Oncology, and General Surgery. The company recently expanded its operations by operationalizing a dedicated Cancer Hospital unit in late 2024, significantly enhancing its service portfolio.

Key Points

  • Key Facts: Founded in 2005 and headquartered in Dhanbad, Jharkhand, Asarfi Hospital Ltd. is listed on the BSE (Scrip Code: 543943). It operates as a primary healthcare entity in its region.
  • Operations and Resources: The company operates a Super-Specialty Hospital unit and a newly established Cancer Hospital unit. As of late 2025, the total bed capacity across both units stood at 330, with 277 effective beds.
  • Ownership: The promoter group holds a 61.17% stake in the company as of March 2025. The remaining shares are held by public shareholders, including Alternative Investment Funds (AIF) and individual investors.
  • Market and Significance: Asarfi Hospital is a critical healthcare provider in the Dhanbad region, offering specialized treatments that were previously less accessible locally. Its strategic importance is underlined by its role as a super-specialty center in Jharkhand.
  • Business Model and Core Competencies: The company follows a healthcare service model, generating revenue through In-Patient Department (IPD) and Out-Patient Department (OPD) services, as well as the sale of medicines. It excels in delivering specialized surgical and medical interventions, particularly in cardiology and oncology.
  • Revenue Breakdown (FY2025 - Annual):
    • Hospital and Medical Care: ₹11,356.63 Lakhs (94.20% of total turnover).
    • Trade of Medicine: ₹699.95 Lakhs (6.75% of total turnover).
    • Geographical Focus: Operations are concentrated in Dhanbad, Jharkhand, India.
  • Key Products and Technology:
    • The company has implemented advanced diagnostic and surgical tools, including Intravascular Ultrasound (IVUS) for intracoronary imaging, expected to be fully operational by March 2026.
    • Specialized units include Medical Oncology, Surgical Oncology, and Radiation Oncology.
  • Subsidiaries: The company has a wholly-owned subsidiary, Asarfi Educational Foundation, which focuses on medical education and training.
  • Strategic Initiatives:
    • Operationalization of the new Cancer Hospital to capture the growing demand for oncology services.
    • Integration of advanced medical technologies like IVUS to improve clinical outcomes and premium procedural billings.
    • Focus on increasing Average Revenue Per Occupied Bed (ARPOB), which rose to ₹24,293 for the Super-Specialty unit and ₹43,240 for the Cancer unit in Q3 FY2026.
  • Future Outlook: The company aims for higher patient retention and referral growth through its specialized cancer care and advanced cardiac imaging capabilities.

Financial Performance (FY2025 Consolidated)

  • Total Income: ₹12,809 Lakhs (48% YoY growth compared to ₹8,607 Lakhs in FY2024).
  • EBITDA: ₹2,355 Lakhs with an EBITDA Margin of 19%.
  • PAT: ₹1,058 Lakhs with a PAT Margin of 9% (compared to ₹416 Lakhs in FY2024).

References

  1. Annual Report Jan 2025
  2. Annual Report May 2025
  3. Investor Presentation Nov 2025
  4. Investor Presentation Feb 2026

Asarfi Hospital FAQ

Asarfi Hospital today is trading in the red, down by 3.75% at ₹173.2.
Asarfi Hospital is currently trading down 3.75% on an intraday basis. In the past week the stock fell 5.36%. Stock has been down 29.02% in the past quarter and fell 15.18% in the past year. You can view this in the share price history/seasonality section.
Asarfi Hospital is listed on BSE with ticker 543943. It's currently trading on BSE at a share price of ₹173.2.
The market cap of Asarfi Hospital is ₹340.81 Cr. as of Nov 19, 2026.
Asarfi Hospital has never announced any dividend since the time of its listing on the BSE exchange.
Asarfi Hospital has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.
Asarfi Hospital reported ₹53.72 Cr. in revenue, ₹6.09 Cr. in net profit, and ₹12.57 Cr. in EBITD as of Nov 16, 2026 for Q2 FY26-27.
There are no analyst predictions for stock price target for Asarfi Hospital.
The PE ratio of Asarfi Hospital is 20.46 as of Nov 19, 2026.
The PB ratio of Asarfi Hospital is 3.34 as of Nov 19, 2026.
There are no analyst reports for Asarfi Hospital.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.